Nice — below is a compact, research-style market reference for the Anti-snoring Devices & Snoring Surgery market: market size / growth figures, major players with business-role notes, and concise answers for each section you requested. I pulled industry reports and market sources so the most important statements are cited.

This versatile research report is presenting crucial details on market relevant information, harping on ample minute details encompassing a multi-dimensional market that collectively maneuver growth in the global Anti-snoring Devices and Snoring Surgery market.

This holistic report presented by the report is also determined to cater to all the market specific information and a take on business analysis and key growth steering best industry practices that optimize million-dollar opportunities amidst staggering competition in Anti-snoring Devices and Snoring Surgery market.

Read complete report at: https://www.thebrainyinsights.com/report/anti-snoring-devices-and-snoring-surgery-market-13719

Market snapshot (select figures)

• Market size (recent): estimates vary by source — ≈ USD 0.8–1.7 billion in 2023–2024 (different reports use different scopes). 

• Forecast / CAGR: common forecasts range ~7–10% CAGR depending on horizon (e.g., MarketsandMarkets ~9.8% to 2029; several sources show mid-single to high-single digit CAGRs).

• Device / procedure mix: Mandibular advancement devices (MADs) are often the largest device segment (reported ~39% share in one study); among surgeries, uvulopalatopharyngoplasty (UPPP) has been a dominant surgery segment (~30% revenue share in 2024 in one report).

Key companies (reference + role / value notes)

(Companies below are repeatedly listed across market reports as leading players)

1. ResMed — major global player in sleep/respiratory devices (CPAP, oral appliance partnerships); reported among top market-sharers in 2024. 

2. Philips Respironics (Koninklijke Philips) — large OEM in CPAP/respiratory devices and sleep therapy product lines.

3. Fisher & Paykel Healthcare — notable in nasal interfaces and home-respiratory devices; named among leading vendors.

4. SomnoMed (SomnoMed Limited) — specialist in custom mandibular advancement devices (MADs); frequently listed as a top MAD manufacturer.

5. Medtronic / LivaNova / ProSomnus / Vivos / DynaFlex — companies that appear in multiple reports either via surgical devices, nerve stimulation (hypoglossal stimulators), or oral appliance portfolios.

6. Smaller/consumer brands (ZQuiet, SleepTight, SnoreMeds, Airway Management, Apnea Sciences, Tomed GmbH, etc.) — many appear in product lists and consumer rankings.

Note on “values” (revenues / market shares): most public market summaries give aggregate market numbers and sometimes segment shares (e.g., MAD share, UPPP share). Vendor-level revenue/share data for this specific combined market (devices + surgery) is fragmented in public reports — vendor ranking is consistent across sources but exact % market share per vendor typically requires paywalled report tables. Representative market totals and segment shares are cited above.

Recent developments

• Growth of non-invasive solutions & smart wearables: increasing adoption of consumer/tracked solutions (positional trainers, smart wearables) and clinically validated MADs.

• Hypoglossal nerve stimulation (implantable) gaining traction as a surgical/therapy alternative for selected OSA/snoring patients and forecast to show faster growth than some older surgery subtypes.

• Consolidation & partnerships between device OEMs, sleep clinics, and dental networks to widen access to oral appliance therapy.

Drivers

• Rising prevalence / diagnosis of sleep-disordered breathing and greater awareness of health impacts.

• Aging & obesity trends (population aging, rising obesity) increase target population for snoring/OSA interventions.

• Preference for less-invasive, home-based treatments (MADs, nasal devices, positional therapy) vs. major surgery.

Restraints

• High cost and reimbursement uncertainty for some devices and surgical procedures — limits uptake in price-sensitive markets.

• Fragmented regulatory / clinical-evidence requirements for some consumer anti-snoring products cause variability in clinician adoption. 

Regional segmentation analysis (high level)

• North America: largest revenue share in most reports — strong diagnosis rates, established reimbursement, high device adoption.

• Europe: mature market with growing uptake of oral appliances and select surgical innovations.

• Asia-Pacific: fastest growth potential due to large populations, rising awareness, growing healthcare spending — but adoption varies by country. 

• Latin America / MEA: smaller share today; growth linked to awareness and affordability improvements.

Emerging trends

• Implantable hypoglossal nerve stimulators (for selected OSA/snoring cases).

• Digitally-enabled oral appliances (scan-based/custom MADs, tele-dentistry fit & follow-up).

• Consumer-tech convergence — wearables, smartphone apps and positional devices becoming part of care pathways for mild-to-moderate cases.

Top use cases

1. Home-based symptomatic snoring reduction (MADs, tongue-retaining devices, positional trainers).

2. Mild-to-moderate OSA management when CPAP is intolerable — MADs and alternative therapies.

3. Surgical intervention for anatomical causes or when non-invasive therapy fails (UPPP, RF ablation, hypoglossal stimulation).

Major challenges

• Heterogeneous evidence for many consumer products — clinicians prefer evidence-based MADs and CPAP; consumer devices must clear trust barrier.

• Cost & reimbursement fragmentation across geographies — a barrier to wider adoption of higher-cost therapies.

• Patient adherence — long-term compliance to oral appliances or positional devices varies.

Attractive opportunities

• Tele-dentistry + digital workflow for custom MADs — reduce fit time and cost, expand reach into underserved markets.

• Adjacencies with consumer sleep/health wearables — bundled solutions for screening and early intervention.

• Hypoglossal stimulation & targeted surgical tech — premium, high-margin growth in select clinical segments.

Key factors of market expansion (summary)

• Greater diagnosis + awareness, aging/obesity demographics, technology innovation (implantables, custom MADs, digital fitting), and better distribution/partnerships (sleep clinics + dental networks) are the primary expansion drivers; cost/reimbursement and evidence/adherence are the main brakes.

Quick bibliography (sources used)

•  Anti-snoring devices market report.

• Anti-Snoring Devices market (segment shares for MADs / UPPP).

•  Reports & Data / Persistence Market Research — assorted market sizes, forecasts, and vendor lists.

• ResearchAndMarkets / industry vendor lists and product/company mentions.

• Sleep Foundation — consumer testing and clinical perspective on mouthpieces.

If you want, I can:

• produce a one-page Excel (CSV) table mapping top 15 vendors → product types → evidence level → likely market role (I can pull vendor lists and populate columns from the reports above), or

• produce a short investor slide (3–5 slides) summarizing opportunity + competitor positioning + recommended entry strategy.

Which output would help you next?